| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-05 |